SPTA1 Polyclonal Antibody

Catalog number E-AB-19527-01

Choose a variant (4 options)

Selecting a variant updates its price, size and availability.

Price for E-AB-19527-01

Size / count 20 µL

Specifications

Catalog number: E-AB-19527-01
Size / count: 20 µL
Dry ice: No
Hazardous: No
Discontinued: No
Background: Spectrin is an actin crosslinking and molecular scaffold protein that links the plasma membrane to the actin cytoskeleton, and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. It is a tetramer made up of alpha-beta dimers linked in a head-to-head arrangement. This gene is one member of a family of alpha-spectrin genes. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms weaker tetramer interactions than non-erythrocytic alpha spectrin, which may increase the plasma membrane elasticity and deformability of red blood cells. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis type 2, pyropoikilocytosis, and spherocytic hemolytic anemia.
Abbreviation: SPTA1
UniProt: P02549
Host: Rabbit
Reactivity: Human; Mouse
Immunogen: Synthetic peptide of human SPTA1
Target: Alpha I spectrin; EL 2; EL2; Elliptocytosis 2; Elliptocytosis2; Erythrocyte alpha spectrin; erythrocyte; Erythroid alpha spectrin; Erythroid alpha-spectrin; Erythroid spectrin alpha; HPP; HS3; Spectrin alpha chain; Spectrin alpha chain erythrocyte; Spectrin alpha erythrocytic 1; SPH3; SPTA 1; SPTA; SPTA1; SPTA1
Clonality: Polyclonal
Conjugation: Unconjugated
Applications: WB; IHC
Field of Research: Cancer; Cardiovascular; Signal transduction
Purification: Antigen affinity purification
Concentration: 1.7 mg/mL
Dilution: WB 1:500-1:2000; IHC 1:60-1:450
Buffer: PBS with 0.05% NaN3 and 40% Glycerol, pH7.4
Shipping Conditions: The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.
Storage Conditions: Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Calculated Molecular Weight: 280 kDa
Observed Molecular Weight: Refer to figures
Isotype: IgG

Frequently Asked Questions

What is the catalog number for SPTA1 Polyclonal Antibody?

The catalog number for SPTA1 Polyclonal Antibody is E-AB-19527.

What sizes are available for SPTA1 Polyclonal Antibody?

SPTA1 Polyclonal Antibody is available in the following size(s): 20 µL, 60 µL, 120 µL, 200 µL.

How many pack sizes does SPTA1 Polyclonal Antibody come in?

SPTA1 Polyclonal Antibody is available in 4 different pack sizes.

Is SPTA1 Polyclonal Antibody in stock?

SPTA1 Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures SPTA1 Polyclonal Antibody?

SPTA1 Polyclonal Antibody is manufactured by Elabscience.

What is the estimated delivery time for SPTA1 Polyclonal Antibody?

Estimated delivery time for SPTA1 Polyclonal Antibody is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for SPTA1 Polyclonal Antibody?

The safety data sheet for SPTA1 Polyclonal Antibody is available here: https://789.bio/eb/4q5eP8.

What is the shelf life of this product?

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

What expression system was used for this recombinant protein?

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Can I return this product if I ordered the wrong one?

As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.